Charts on Near Term Uotrends Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts on Near Term Uotrends

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Senior who wrote (1222)	9/9/2009 4:21:03 PM
From: Jibacoa	Read Replies (1) of 1404

Paul, PARD is not a stock for you.<g> I am not considering buying it either,was just answering a comment made by naturalgass. As you said, the insiders would buy "because they know something". And they bought in Dec,Jan & March before the start of the up-move from the $2 to the $9 level.<g> They don't report revenues, just the losses that they started to trim down some in the 2ndQ and are expected to be down to around $1.22 from the $1.41 loss of last Yr. and to around $1.10 in 2010 Sometimes biotechnological companies can often give pleasant as well as disappointing surprises, like VVUS today, which I commented on another thread. VVUS had reported two consecutive Qs of lower revenues and in the last Q it had reported a loss of $0.19 vs. $0.06 on the black last Yr and the EL for 2009 is around $0.88 vs. $0.16 in 2008. But "somebody knew something" and it started to move up slowly last week, closing near its intraday H yesterday before its news, and today it is trading above its Hs for the last 10 Yrs.<g> (I used to be long the stock years ago when it was trying to beat PFE to market with a drug for ED, but of course,PFE won that race and was able to market Viagra.<g>) Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next